Please assess the completion status of the following clinical trial:

Trial Title: Effect of Furosemide on Obesity-induced Glomerular Hyperfiltration

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* 10 obese men (BMI\>30), aged 18 to 55, with glomerular hyperfiltration (creatinine clearance\>130 ml/min) will be included in the study.~Exclusion Criteria:~* Any of the following conditions:~  * Heart failure~ * Known allergy to furosemide, inulin or amino-hippurate~ * Pharmacologic treatment for hypertension, cardiac disease, diabetes mellitus~ * Treatment with corticosteroids or NSAID

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Furosemide, obesity, glomerular hyperfiltration (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).